Aluminium could aid delivery of chemotherapy drugs
Aluminium could be key for the effective and efficient adsorption of chemotherapy drugs for targeted delivery and reduced side effects...
List view / Grid view
Aluminium could be key for the effective and efficient adsorption of chemotherapy drugs for targeted delivery and reduced side effects...
Researchers have outlined a simple method to increase the number of injection-drug taking individuals with HIV to adhere to their medication...
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
Senescent, or zombie cells, are being targeted with the development of a new nanocarrier drug delivery system.
The crystal structure was found to have a half-life of 24 hours and could last in the bloodstream for more than 96 hours...
Inhibiting protein kinase C-alpha was shown to be a pivotal step towards restoring the damage done by nephritis...
Tiny drug-filled nanocarriers, termed ‘nano-submarines’, are being developed to boost the targeted treatment of headaches and tumours, without damaging healthy tissue...
2 July 2018 | By SCIEX
Different modalities of monoclonal antibodies are pushing the limits of characterization by MS: new critical quality attributes need to be carefully monitored from developability in early phases and then during process development and clinical phases...
The FDA has approved a diabetes management device that is intended to automatically monitor glucose and provide appropriate basal insulin doses with little or no input from the user...
Device can deliver drugs, proteins and stem cells directly to diseased tissue...
Bioengineers may be able to use the unique mechanical properties of diseased cells, such as metastatic cancer cells, to help improve delivery of drug treatments to the targeted cells...
Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes...
Protein inhibits inflammatory response underlying chronic pain processing may provide an alternative to opioids for severe, persistent pain...
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumours...